An implantable, microchip-based device that may soon replace the injections and pills now needed to treat chronic diseases has been developed by MIT spinoff Microchips Biotech. The microchips consist of hundreds of pinhead-sized reservoirs, each capped with a metal membrane, that store tiny doses of therapeutics or chemicals. An electric current delivered by the device removes the membrane, releasing a single dose. The device can be programmed wirelessly to release individual doses for up to 16 years to treat, for example, diabetes (lat. Diabetes Mellitus), cancer (lat. Carcinoma), multiple sclerosis (lat. Sclerosis multiplex), and osteoporosis.